Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease

Authors

Remo Panaccione (ORCID: https://orcid.org/0000-0002-5247-940X)
Wan‐Ju Lee (ORCID: https://orcid.org/0000-0001-9263-6943)
Kristina Kligys
Koji Kamikozuru (ORCID: https://orcid.org/0000-0002-5474-3008)
Jasmina Kalabic (ORCID: https://orcid.org/0009-0007-4698-1042)
Stefan Schreiber
Christopher Ma (ORCID: https://orcid.org/0000-0002-4698-9948)
Marc Ferrante
Namita Joshi (ORCID: https://orcid.org/0000-0001-5577-2890)
Jean–Frédéric Colombel
Jenny Griffith
Brian G. Feagan
Marla Dubinsky
Si Xuan

Institutions

Western University (CA)
Hyogo Medical University (JP)
University of Calgary (CA)
AbbVie (United States) (US)
University Hospital Schleswig-Holstein (DE)
AbbVie (Germany) (DE)
University of Lübeck (DE)
Icahn School of Medicine at Mount Sinai (US)
KU Leuven (BE)

Publication Details

Journal: Gastro Hep Advances
Published: 2024-09-06
DOI: https://doi.org/10.1016/j.gastha.2024.08.022
Citations: 2
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 1.10

Funders

AbbVie
AbbVie Canada

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease

Remo Panaccione, Wan‐Ju Lee, Kristina Kligys, Koji Kamikozuru et al.

Sep 6, 2024

2 citations

Gastro Hep Advances

Inflammatory Bowel Disease

1.10

article

Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease

Remo Panaccione, Wan‐Ju Lee, Kristina Kligys, Koji Kamikozuru, Jasmina Kalabic, Stefan Schreiber, Christopher Ma, Marc Ferrante, Namita Joshi, Jean–Frédéric Colombel, Jenny Griffith, Brian G. Feagan, Marla Dubinsky, Si Xuan

September 6, 2024article en

2 citations

Abstract

No abstract available for this paper.

Gastro Hep AdvancesVol. 4(1)

Western University (CA), Hyogo Medical University (JP), University of Calgary (CA), AbbVie (United States) (US), University Hospital Schleswig-Holstein (DE), AbbVie (Germany) (DE), University of Lübeck (DE), Icahn School of Medicine at Mount Sinai (US), KU Leuven (BE)

AbbVie, AbbVie Canada

Good health and well-being

Openalex Percentile: Top 19%

Inflammatory Bowel Disease

1.10

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.